Dr. Anders Wimo

Anders Wimo became an associate professor of Family Medicine in Umeå in 1995.Currently he is responsible for the health economic research at Stockholm Gerontology Research Center.
...
Dr Wimo has written several reports for the National Board of Health and Welfare (NBHW) in Sweden.Anders Wimo is also a member of the managing team of SNAC, (Swedish National study on Aging and Care) which is a longitudinal national database of the elderly, which has its origin from the Ministry of Social Affairs He is a member of the International Psychogeriatric Association (IPA) and the International Working Group for Harmonization of Dementia Drug Guidelines.

He has also participated in several EU-projects.Currently he is also part of a dementia project at SBU (Statens Beredning for medicinsk Utvärdering - The Swedish Council on Technology Assessment in Health Care) where dementia care is evaluated from a evidence based medicine-perspective.

He was also a member of an expert group that in a workshop for the Swedish Medical products Agency evaluated drug treatment of dementia.Currently he is also preparing a report by the Swedish Ministry of Social affairs for OECD and he is also a member of a working group for the ministry about dementia care.His publication list consists of about 140 publications and he has written several chapters in text books, mainly about the health economics of dementia.

"Alzheimer's is one of the three most expensive diseases in the world, alongside cancer and heart disease," said Dr Anders Wimo, associate professor of family medicine at the University of Umea in Sweden.West European countries spend $94 billion to $122 billion a year on treating and caring for dementia patients, and the United States spends at least $100 billion a year on treatment and care for Alzheimer's patients alone, Wimo said.